References
1. N.S. Dey, S. Majumdar, and M.E.B. Rao, Trop. J. Pharm. Res.
7 (3), 1067–1075 (2008).
2. N. Follonier and E. Doelker, S.T.P. Pharma Sci.
2 (2), 141–158 (1992).
3. A.S. Abdul, A.V. Chandewar, and S.B. Jaiswal, J. Control. Release
147 (1), 2–16 (2010).
4. FASS 2002, A.G. Hedstrand, Ed. (LINFO, Stockholm, 2002), pp. 853–854.
5. R. Bodmeier, Eur. J. Pharm. Biopharm.
43 (1), 1–8 (1997).
6. A.E.K. Lundqvist, F. Podczeck, and J.M. Newton, Eur. J. Pharm. Biopharm.
46 (3), 369–379 (1998).
7. H. Leuenberger, Int. J. Pharm.
12 (1), 41–55 (1982).
8. C. Sun and D.J.W. Grant, Pharm. Dev. Technol.
6 (2), 193–200 (2001).
9. J. Van der Zwan and C.A.M. Siskens, Powder Technol.
33 (1), 43–54 (1982).
10. B. Johansson and G. Alderborn, Int. J. Pharm.
132 (1–2), 207–220 (1996).
11. J.B. Schwartz, N.H. Nguyen, and R.L. Schnaare, Drug Dev. Ind. Pharm.
20 (20), 3105–3129 (1994).
12. F. Nicklasson and G. Alderborn, Eur. J. Pharm. Sci.
9 (1), 57–65 (1999).
13. C. Wang et al., Drug Dev. Ind. Pharm.
21 (7), 753–779 (1995).
14. N.O. Iloanusi and J.B. Schwartz, Drug Dev. Ind. Pharm.
24 (1), 37–44 (1998).
15. M. Salako, F. Podczeck, and J.M. Newton, Int. J. Pharm.
168 (1), 49–57 (1998).
16. M.E. Aulton, A.M. Dyer, and K.A. Khan, Drug Dev. Ind. Pharm.
20 (20), 3069–3104 (1994).
17. J.L. Haslam et al., Int. J. Pharm.
173 (1–2), 233–242 (1998).
18. B. Johansson, F. Nicklasson, and G. Alderborn, Int. J. Pharm.
163 (1–2), 35–48 (1998).
19. N Sarisuta and K. Punpreuk, J. Control. Release
31 (3), 215–222 (1994).
20. S.C. Porter, Drug Dev. Ind. Pharm.
15 (10), 1495–1521 (1989).
21. M.P. Flament et al., Pharm. Technol. Eur.
6 (2), 19–25 (1994).
|
